Retirement Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.44K Hold
50
﹤0.01% 685
2023
Q4
$1.64K Hold
50
﹤0.01% 656
2023
Q3
$1.39K Hold
50
﹤0.01% 615
2023
Q2
$1.71K Hold
50
﹤0.01% 630
2023
Q1
$2K Hold
50
﹤0.01% 572
2022
Q4
$1K Hold
50
﹤0.01% 556
2022
Q3
$2K Hold
50
﹤0.01% 385
2022
Q2
$2K Hold
50
﹤0.01% 607
2022
Q1
$2K Hold
50
﹤0.01% 611
2021
Q4
$3K Hold
50
﹤0.01% 565
2021
Q3
$4K Hold
50
﹤0.01% 463
2021
Q2
$5K Sell
50
-2,273
-98% -$193K ﹤0.01% 479
2021
Q1
$206K Buy
+2,323
New +$230K 0.09% 130

Other funds holding ARKG

Retirement Group's ARKG Position: Q1 2024 in Review

Retirement Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2024 at 50 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Retirement Group first reported a position in ARKG in Q1 2021 and has held it in 13 quarters since. The position peaked at $206K in Q1 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Retirement Group held 50 shares of ARK Genomic Revolution ETF worth $1.44K as of Q1 2024.
  • Retirement Group left its ARK Genomic Revolution ETF share count unchanged in Q1 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #685 holding.
  • Retirement Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 13 quarters since.
  • Retirement Group's ARK Genomic Revolution ETF position peaked at $206K in Q1 2021.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.